Tsuruha Holdings Inc. (TYO:3391)
Japan · Delayed Price · Currency is JPY 2,655.00
-15.00 (-0.56%)
Oct 24, 2025, 3:30 PM JST
Tsuruha Holdings Revenue
In the fiscal year ending February 28, 2025, Tsuruha Holdings had annual revenue of 1.01T JPY, down -1.24%. Tsuruha Holdings had revenue of 285.30B in the quarter ending August 31, 2025, with 4.42% growth.
Revenue (ttm)
1.10T
Revenue Growth
+6.96%
P/S Ratio
0.64
Revenue / Employee
89.81M
Employees
11,298
Market Cap
647.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 1.01T | -12.74B | -1.24% |
| May 15, 2024 | 1.03T | 57.38B | 5.92% |
| May 15, 2023 | 970.08B | 54.38B | 5.94% |
| May 15, 2022 | 915.70B | -3.60B | -0.39% |
| May 15, 2021 | 919.30B | 78.27B | 9.31% |
| May 15, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 15, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 15, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 15, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 15, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.48T |
| Otsuka Holdings | 2.40T |
| Astellas Pharma | 1.94T |
| Daiichi Sankyo Company | 1.92T |
| Chugai Pharmaceutical | 1.20T |
| Terumo | 1.04T |
| Olympus | 969.02B |
| HOYA Corporation | 876.09B |